Sarcomatoid Carcinoma of the Prostate With Both Chondrosarcomatous and Osteosarcomatous Differentiation Following Androgen Deprivation Therapy: A Case Report and Diagnostic Considerations
- 22 July 2026
- journal article
- Published by SAGE Publications in International Journal of Surgical Pathology
Abstract
Background: Sarcomatoid carcinoma of the prostate is a rare and aggressive biphasic malignancy, typically arising in the setting of prior prostatic adenocarcinoma. Prominent heterologous differentiation may obscure its epithelial origin and lead to diagnostic confusion with primary mesenchymal tumors. Case presentation: We report an 80-year-old man with a history of metastatic prostate adenocarcinoma treated with androgen deprivation therapy, who presented with acute urinary obstruction and low prostate-specific antigen levels. Transurethral resection revealed a highly heterogeneous tumor composed of extensive cartilaginous and high-grade sarcomatoid components, including both chondrosarcomatous and osteosarcomatous differentiation. Despite thorough histopathological examination, no epithelial component was identified. Prior pathology confirmed adenocarcinoma up to 9 months earlier, with evidence of sarcomatoid transformation emerging in recent specimens. Immunohistochemistry supported mesenchymal differentiation. Based on clinicopathological correlation, a diagnosis of sarcomatoid carcinoma of the prostate with heterologous differentiation was established. Conclusion: This report highlights a significant diagnostic pitfall in which sarcomatoid carcinoma may mimic primary sarcoma when the sarcomatoid component predominates and epithelial elements are absent. It also underscores the potential role of androgen deprivation therapy in tumor dedifferentiation and the limitations of PSA in monitoring disease progression. Awareness of this entity is essential for accurate diagnosis and appropriate clinical management.Keywords
This publication has 10 references indexed in Scilit:
- Case report: Two cases of prostate adenocarcinoma progressing to rare sarcomatoid carcinoma with normal PSA levels following endocrine therapyFrontiers in Oncology, 2024
- Prostatic carcinosarcoma seven years after radical prostatectomy and hormonal therapy for prostatic adenocarcinoma: A case reportWorld Journal of Clinical Cases, 2021
- Sarcomatoid carcinoma of the prostate with bladder invasion shortly after androgen deprivation: Two case reportsWorld Journal of Clinical Cases, 2021
- Sarcomatoid Carcinoma of the Prostate: Retrospective Review of a Case Series From the Johns Hopkins HospitalUrology, 2015
- Rare and unusual histological variants of prostatic carcinoma: clinical significanceBJU International, 2008
- Sarcomatoid carcinoma after radiation treatment of prostatic adenocarcinomaAnnals of Diagnostic Pathology, 2008
- Sarcomatoid Carcinoma of the Prostate: A Study of 42 CasesAmerican Journal of Surgical Pathology, 2006
- Carcinosarcoma of the ProstateUrologia Internationalis, 1997
- Carcinosarcoma of the prostate. Report of 21 casesCancer, 1995
- Sarcomatoid carcinoma of the prostate a clinicopathologic study of 12 patientsCancer, 1992